SA36 Is Progression-Free Survival a Good Indicator of Overall Survival for Pazopanib in Patients With Synovial Sarcoma?
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.2430
https://www.valueinhealthjournal.com/article/S1098-3015(22)04635-6/fulltext
Section Title :
Section Order :
11992
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04635-6&doi=10.1016/j.jval.2022.09.2430